FDA Drug recall D-0875-2018
Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvi…
- FDA Drug
- Class I
- terminated
- Published 2018-06-20
On 2018-06-20 the FDA classified a Class I recall of Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvi… by Allergan, citing contraceptive Tablets Out of Sequence.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0875-2018 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2018-05-24 |
| Published | 2018-06-20 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Allergan |
| Distribution | US |
Product
Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvine, CA 92612 NDC 0023-5862-28 (Blister Card) NDC 0023-5862-29 (Blister Carton) NDC 0023-5862-31 (Outer carton) UPC 300235862290
Reason
Contraceptive Tablets Out of Sequence.
Identifiers
| upc | 300235862290 |
|---|---|
| ndc | 0023-5862-28 |
| ndc | 0023-5862-30 |
| ndc | 0023-5862-29 |
| ndc | 0023-5862-31 |
| ndc | 3002358622 |
| code_info | Lot# 5620706, Exp. 05/19 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0875-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.